Cargando…

Alpinetin suppresses CYP3A4, 2C9, and 2E1 activity in vitro

CONTEXT: Alpinetin, the major active constitutes of Alpinia katsumata Hayata (Zingiberaceae), has been demonstrated to possess the activity of anti-breast cancer. Cytochrome P450 enzymes (CYP450s) plays vital roles in the biotransformation of various drugs. OBJECTIVE: To assess the effect of alpinet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Hongming, Wei, Chuankui, Yang, Wu, Niu, Zhaohe, Gong, Mingkai, Hu, Haiyan, Wang, Haibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154758/ https://www.ncbi.nlm.nih.gov/pubmed/35634649 http://dx.doi.org/10.1080/13880209.2022.2071450

Ejemplares similares

Alpinetin: anti-human gastric cancer potential and urease inhibition activity in vitro
por: Zhang, Hui, et al.
Publicado: (2021)

Alpinetin: A Review of Its Pharmacology and Pharmacokinetics
por: Zhao, Ge, et al.
Publicado: (2022)

Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model
por: Liu, Yukun, et al.
Publicado: (2021)

Alpinetin Suppresses Zika Virus-Induced Interleukin-1β Production and Secretion in Human Macrophages
por: Wikan, Nitwara, et al.
Publicado: (2022)

Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1 in vitro
por: Zhang, Guiying, et al.
Publicado: (2021)

Protective effect of Alpinetin on rats with chronic obstructive pulmonary disease
por: Su, Yu, et al.
Publicado: (2020)

Functional characterization of the defective CYP2C9 variant CYP2C9*18
por: Liu, Jian, et al.
Publicado: (2021)

In vitro inhibitory effect of obtusofolin on the activity of CYP3A4, 2C9, and 2E1
por: Liu, Na, et al.
Publicado: (2021)

Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium
por: TANG, BO, et al.
Publicado: (2011)

Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells
por: DU, JIAN, et al.
Publicado: (2012)

Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells
por: Du, Jian, et al.
Publicado: (2023)

Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population
por: Kudzi, William, et al.
Publicado: (2009)

Global variation in CYP2C8–CYP2C9 functional haplotypes
por: Speed, William C, et al.
Publicado: (2009)

Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis
por: He, Xuexiu, et al.
Publicado: (2016)

Alpinetin Suppresses Effects of TGF-β1 on Stimulating the Production and Organization of Fibrotic Markers in Human Primary Dermal Fibroblasts
por: Wikan, Nitwara, et al.
Publicado: (2022)

[Retracted] Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis‑diammined dichloridoplatium
por: Tang, Bo, et al.
Publicado: (2023)

Activation of PXR by Alpinetin Contributes to Abrogate Chemically Induced Inflammatory Bowel Disease
por: Yu, Zhilun, et al.
Publicado: (2020)

Alpinetin promotes hair regeneration via activating hair follicle stem cells
por: Fan, Xiaojiao, et al.
Publicado: (2022)

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies
por: Desrivot, Julie, et al.
Publicado: (2021)

In vitro and In silico studies of interactions of cathinone with human recombinant cytochrome P450 CYP(1A2), CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2, and CYP3A5
por: Lim, Sharoen Yu Ming, et al.
Publicado: (2022)

The Effects of H(2)S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat
por: Wang, Xianqin, et al.
Publicado: (2013)

Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
por: Liu, Renhe, et al.
Publicado: (2017)

CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
por: Johansson, Maria, et al.
Publicado: (2014)

Metabolic Profiling of Alpinetin in Rat Plasma, Urine, Bile and Feces after Intragastric Administration
por: Qiu, Jieying, et al.
Publicado: (2019)

Preclinical Investigation of Alpinetin in the Treatment of Cancer-Induced Cachexia via Activating PPARγ
por: Zhang, Yujie, et al.
Publicado: (2021)

The Evaluation of CYP2D6, CYP2C9, CYP2C19, and CYP2B6 Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics
por: Giorgetti, Arianna, et al.
Publicado: (2023)

The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
por: Haeggström, Sigrid, et al.
Publicado: (2022)

A Systematically Combined Genotype and Functional Combination Analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in Different Geographic Areas of Mainland China – A Basis for Personalized Therapy
por: Wu, Zhenqiang, et al.
Publicado: (2013)

Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP
por: Tan, Ming‐Liang, et al.
Publicado: (2017)

Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects
por: Wang, Jing, et al.
Publicado: (2018)

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population
por: Ota, Tomoko, et al.
Publicado: (2015)

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy
por: Lakhan, Ram, et al.
Publicado: (2011)

CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants
por: Zhang, Lingxin, et al.
Publicado: (2020)

Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?
por: Yasar, Umit
Publicado: (2018)

Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury
por: Xiao, Shining, et al.
Publicado: (2023)

Association of CYP2C9 Genetic Variants with Vitiligo
por: Alzolibani, Abdullateef A., et al.
Publicado: (2014)

Pharmacogenomics of CYP2C9: Functional and Clinical Considerations(†)
por: Daly, Ann K., et al.
Publicado: (2017)

Relevance of CYP2C9 Function in Valproate Therapy
por: Monostory, Katalin, et al.
Publicado: (2019)

Noncompetitive inhibition of human CYP2C9 in vitro by a commercial Rhodiola rosea product
por: Thu, Ole Kristian Forstrønen, et al.
Publicado: (2017)

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
por: Zhao, Fang-Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2rd2d71kis2dj3ie6j903qsd8g